Compare Smith & Nephew plc (SNN) vs Sprott Uranium Miners ETF (URNM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Smith & Nephew plc vs Sprott Uranium Miners ETF — how do they compare? Smith & Nephew plc trades at $27.21 (market cap $11.10B), while Sprott Uranium Miners ETF trades at $46.23 (market cap $1.87B). The key difference: Smith & Nephew plc is far larger — about 5.9× Sprott Uranium Miners ETF's market cap, and Smith & Nephew plc pays a 2.95% dividend while Sprott Uranium Miners ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Smith & Nephew plc for 121 Days and Sprott Uranium Miners ETF for 61 Days on average.
| SNN | URNM | |
|---|---|---|
Market Cap | $11.10B | $1.87B |
Volume | 1,051,703 | 1,586,926 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $37.17 | $83.99 |
52-Week Low | $26.42 | $46.09 |
Typical Hold Time | 121 Days | 61 Days |
Enterprise Value | $14.13B | — |
Dividend Yield | 2.95% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Smith+Nephew (SNN) trades at $27.24, near its 52-week low of $27.05, with a bearish technical signal despite recent earnings beats. Revenue grew to $6.16B in 2025, with net income margin improving to 10.08%, but the stock faces headwinds from analyst downgrades and CFO departure news. Product launches like the EVOS PELVIC System highlight innovation, yet investor sentiment remains cautious.
The outlook is mixed: strong fundamentals and undervaluation (P/E 18.34) offer upside, but technical weakness and competitive risks temper near-term gains. Key risks include execution challenges and market volatility, while institutional interest (e.g., BlackRock's $505M stake) provides support. Investors should weigh solid profitability against sentiment-driven price pressure.
URNM trades at $46.50, down 2.86% today amid bearish technical signals with 19 sell indicators versus 4 buy. The ETF faces resistance near $47 while finding support at $45-46 levels. Recent news highlights uranium's long-term growth potential driven by AI energy demand and nuclear expansion, though short-term volatility persists.
The uranium mining ETF benefits from structural supply deficits and government nuclear investments, but faces near-term price pressure. Key risks include commodity price volatility and execution challenges among constituent miners. Analyst sentiment remains mixed with bullish long-term themes offset by technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →About Sprott Uranium Miners ETF
URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →
